UCSF’s innovative, collaborative approach to patient care, research and education spans disciplines across the life sciences, making it a world leader in scientific discovery and its translation to improving health.
Athena studied Integrative Biology and Classics at UC Berkeley. She was involved in archaeological research and assisted the excavation of a prehistoric cemetery in Greece. On campus, she was a volunteer EMT and worked as a chef for her housing cooperative. Her experiences volunteering in hospice and nursing facilities led her to the Memory and Aging Center, where she assists patients, families, and caregivers with the autopsy program.
Morgan is a clinical research coordinator in the Rosen Lab who works on the Alzheimer’s Disease Neuroimaging Initiative (ADNI), Longitudinal Early-Onset Alzheimer’s Disease Study (LEADS) and UCSF Alzheimer’s Disease Research Center (ADRC) studies.
Winnie brings extensive experience in project management, software development and web technologies to the Global Brain Health Institute (GBHI) through her work across many industries including non-profit scientific publishing, biotechnology, human resources software, consulting and legal services.
Rian graduated from UC Santa Barbara in 2018 with a BS degree in Biology and has over five years of research experience at UCSF. As the ALBA Language Neurobiology Lab and Dyslexia Center's Database Architect, he develops and implements database systems for both teams, leveraging his experience in data management, data analysis, and neuroimaging.
Dr. David N. Soleimani-Meigooni is a neurologist who cares for patients experiencing cognitive symptoms as a result of neurodegenerative diseases such as Alzheimer's disease.
In research, Soleimani-Meigooni focuses on advancing precision-medicine approaches to diagnosing Alzheimer's disease and other neurodegenerative diseases. He looks at using positron emission tomography (PET) to image amyloid-beta and tau (protein fragments that accumulate in the brains of people with the condition).
Gloria Aguirre is an artist and community advocate who joined the Memory and Aging Center in 2019. She is an Atlantic Fellow for Health Equity based at George Washington University in Washington D.C. and serves as Artistic Director of Creative Minds, the San Francisco community arts for brain health initiative, and Community Engagement Manager for the Community Outreach Program at the MAC.
Dr. Staffaroni is a clinical neuropsychologist and Associate Professor at the UCSF Memory and Aging Center. His research focuses on improving early detection, prognosis, and monitoring of neurodegenerative diseases through a combination of clinical tests, neuroimaging, and blood-based biomarkers. He leads studies of remote digital data collection in frontotemporal dementia using smartphone assessments and sensor technologies.
Christina Veziris is an assistant clinical research coordinator in the UCSF Clinical Affective Neuroscience (CAN) Lab. She graduated from the University of San Francisco in 2018 with a bachelor’s degree in psychology and minors in neuroscience and health studies. She volunteered in the CAN lab for a year and then worked in the Relationships, Emotions, and Health Lab at San Francisco State University for three years using the Facial Action Coding System to code facial emotions.
Bettina Pedemonte completed a PhD degree in mathematics in Italy at Genoa University and a PhD degree in mathematics education in France at Grenoble University. She has experience in teaching mathematics, in particular to students with learning disorders. She designed technological environments to support mathematical learning. Her research interests include understanding cognitive processes involved in solving mathematical problems and finding new teaching methods to support mathematical learning. Bettina joined UCSF in March 2018, specializing in designing a battery for dyscalculia.
As an Assistant Professor of Neurology at UCSF, Dr. Lawren Vandevrede's overarching goal is to provide outstanding clinical care to patients with dementia and their caregivers. He completed his medical training in Chicago, where he also obtained a PhD degree in neuroscience working with his mentor to develop novel therapeutic agents for the treatment of Alzheimer’s disease.
